These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Racial tensions entangle NIH in dispute over AIDS drug. Anderson C. Nature; 1992 Oct 22; 359(6397):660-1. PubMed ID: 1436022 [No Abstract] [Full Text] [Related]
15. Low-dose oral recombinant interferon-alpha A in patients with HIV-1 infection: a blinded pilot study. Sperber SJ, Gocke DJ, Haberzettl CA, Pestka S. AIDS; 1993 May 10; 7(5):693-7. PubMed ID: 8100421 [Abstract] [Full Text] [Related]
16. Focusing National Institutes of Health HIV/AIDS research for maximum population impact. Walensky RP, Auerbach JD, Office of AIDS Research Advisory Council (OARAC) HIV/AIDS Research Portfolio Review Working Group. Clin Infect Dis; 2015 Mar 15; 60(6):937-40. PubMed ID: 25422391 [Abstract] [Full Text] [Related]
18. Low-dose oral alpha interferon study opens. Randall P. NIAID AIDS Agenda; 1996 Jun 15; ():4-5. PubMed ID: 11363808 [Abstract] [Full Text] [Related]
19. [Immunodeficiency and opportunistic processes in the absence of human immunodeficiency virus infection]. Soriano V, Castro A. Med Clin (Barc); 1993 Mar 06; 100(9):351-5. PubMed ID: 8095996 [No Abstract] [Full Text] [Related]
20. The new AIDS case definition. Implications for San Francisco. Chang SW, Kate MH, Hernandez SR. JAMA; 1992 Feb 19; 267(7):973-5. PubMed ID: 1346406 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]